Annual Working Capital
$13.88 M
-$4.61 M-24.92%
31 December 2023
Summary:
Aileron Therapeutics annual working capital is currently $13.88 million, with the most recent change of -$4.61 million (-24.92%) on 31 December 2023. During the last 3 years, it has risen by +$1.51 million (+12.25%). ALRN annual working capital is now -70.43% below its all-time high of $46.95 million, reached on 31 December 2017.ALRN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$13.03 M
-$5.20 M-28.52%
30 September 2024
Summary:
Aileron Therapeutics quarterly working capital is currently $13.03 million, with the most recent change of -$5.20 million (-28.52%) on 30 September 2024. Over the past year, it has increased by +$1.86 million (+16.62%). ALRN quarterly working capital is now -78.74% below its all-time high of $61.25 million, reached on 31 March 2021.ALRN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALRN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.9% | +16.6% |
| 3 y3 years | +12.3% | -73.9% |
| 5 y5 years | -15.4% | -35.1% |
ALRN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -68.2% | +12.3% | -73.9% | +58.2% |
| 5 y | 5 years | -68.2% | +12.3% | -78.7% | +72.7% |
| alltime | all time | -70.4% | +839.8% | -78.7% | +99.7% |
Aileron Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.03 M(-28.5%) |
| June 2024 | - | $18.22 M(+121.4%) |
| Mar 2024 | - | $8.23 M(-40.7%) |
| Dec 2023 | $13.88 M(-24.9%) | $13.88 M(+24.3%) |
| Sept 2023 | - | $11.17 M(-12.4%) |
| June 2023 | - | $12.76 M(-10.3%) |
| Mar 2023 | - | $14.22 M(-23.1%) |
| Dec 2022 | $18.49 M(-57.7%) | $18.49 M(-17.9%) |
| Sept 2022 | - | $22.52 M(-20.7%) |
| June 2022 | - | $28.40 M(-20.8%) |
| Mar 2022 | - | $35.85 M(-17.9%) |
| Dec 2021 | $43.67 M(+253.1%) | $43.67 M(-12.4%) |
| Sept 2021 | - | $49.86 M(-10.8%) |
| June 2021 | - | $55.88 M(-8.8%) |
| Mar 2021 | - | $61.25 M(+395.3%) |
| Dec 2020 | $12.37 M | $12.37 M(+15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $10.72 M(-27.3%) |
| June 2020 | - | $14.74 M(+95.4%) |
| Mar 2020 | - | $7.54 M(-45.0%) |
| Dec 2019 | $13.71 M(-16.4%) | $13.71 M(-31.7%) |
| Sept 2019 | - | $20.07 M(-26.1%) |
| June 2019 | - | $27.17 M(+178.2%) |
| Mar 2019 | - | $9.77 M(-40.5%) |
| Dec 2018 | $16.41 M(-65.1%) | $16.41 M(-28.5%) |
| Sept 2018 | - | $22.95 M(-25.6%) |
| June 2018 | - | $30.84 M(-22.1%) |
| Mar 2018 | - | $39.59 M(-15.7%) |
| Dec 2017 | $46.95 M(+176.1%) | $46.95 M(-11.6%) |
| Sept 2017 | - | $53.09 M(+714.2%) |
| June 2017 | - | $6.52 M(-50.3%) |
| Mar 2017 | - | $13.11 M(-22.9%) |
| Dec 2016 | $17.00 M(+1051.1%) | $17.00 M |
| Dec 2015 | $1.48 M | - |
FAQ
- What is Aileron Therapeutics annual working capital?
- What is the all time high annual working capital for Aileron Therapeutics?
- What is Aileron Therapeutics annual working capital year-on-year change?
- What is Aileron Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly working capital year-on-year change?
What is Aileron Therapeutics annual working capital?
The current annual working capital of ALRN is $13.88 M
What is the all time high annual working capital for Aileron Therapeutics?
Aileron Therapeutics all-time high annual working capital is $46.95 M
What is Aileron Therapeutics annual working capital year-on-year change?
Over the past year, ALRN annual working capital has changed by -$4.61 M (-24.92%)
What is Aileron Therapeutics quarterly working capital?
The current quarterly working capital of ALRN is $13.03 M
What is the all time high quarterly working capital for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly working capital is $61.25 M
What is Aileron Therapeutics quarterly working capital year-on-year change?
Over the past year, ALRN quarterly working capital has changed by +$1.86 M (+16.62%)